Last updated on September 2020

Study to Prevent Acute Kidney Injury After Cardiac Surgery Involving Cardiopulmonary Bypass


Brief description of study

The objective of the study is to assess the safety and efficacy of ANG-3777 in preventing AKI compared to placebo when administered to patients at risk for developing acute kidney injury (AKI) following cardiac surgical procedures involving cardiopulmonary bypass (CPB).

Clinical Study Identifier: NCT02771509

Find a site near you

Start Over

River City Clinical Research

Jacksonville, FL United States
  Connect »

Suburban Hospital

Bethesda, MD United States
  Connect »

Duke University

Durham, NC United States
  Connect »

Cleveland Clinic Fairview

Cleveland, OH United States
  Connect »

University of Southern California

Los Angeles, CA United States
  Connect »

Bryan Heart

Lincoln, NE United States
  Connect »

University of Virginia Health System

Charlottesville, VA United States
  Connect »

Cedars-Sinai Medical Center

Los Angeles, CA United States
  Connect »

Indiana Ohio Heart

Fort Wayne, IN United States
  Connect »

TriHealth

Cincinnati, OH United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.